132 related articles for article (PubMed ID: 35680279)
41. The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study.
Burton C; Isles C; Norrie J; Hanson R; Grubb E
Br J Gen Pract; 2006 Sep; 56(530):697-702. PubMed ID: 16954003
[TBL] [Abstract][Full Text] [Related]
42. Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation.
Gulløv AL; Koefoed BG; Petersen P
Arch Intern Med; 1999 Jun; 159(12):1322-8. PubMed ID: 10386508
[TBL] [Abstract][Full Text] [Related]
43. Warfarin-induced sublingual hematoma mimicking Ludwig angina: Conservative management of a potentially life-threatening condition.
Cashman E; Shandilya M; Amin M; Hughes J; Walsh M
Ear Nose Throat J; 2011 Feb; 90(2):E1. PubMed ID: 21328214
[TBL] [Abstract][Full Text] [Related]
44. Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial.
Wallentin L; Yusuf S; Ezekowitz MD; Alings M; Flather M; Franzosi MG; Pais P; Dans A; Eikelboom J; Oldgren J; Pogue J; Reilly PA; Yang S; Connolly SJ;
Lancet; 2010 Sep; 376(9745):975-83. PubMed ID: 20801496
[TBL] [Abstract][Full Text] [Related]
45. [Sublingual haematoma as a result of dysregulated peroral anticoagulant therapy].
Lilja-Fischer JK; Lauridsen SV; Nielsen VE
Ugeskr Laeger; 2012 Mar; 174(10):649-50. PubMed ID: 22395015
[TBL] [Abstract][Full Text] [Related]
46. A Therapeutic International Normalized Ratio Results in Smaller Infarcts and Better Outcomes for Patients with Ischemic Stroke.
Merbach D; Lawrence E; Mallick D; Marsh EB
J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104278. PubMed ID: 31326271
[TBL] [Abstract][Full Text] [Related]
47. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation).
Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW
J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196
[TBL] [Abstract][Full Text] [Related]
48. Elevated international normalized ratio associated with concomitant warfarin and erlotinib.
Thomas KS; Billingsley A; Amarshi N; Nair BA
Am J Health Syst Pharm; 2010 Sep; 67(17):1426-9. PubMed ID: 20720241
[TBL] [Abstract][Full Text] [Related]
49. Optimal intensity of international normalized ratio in warfarin therapy for secondary prevention of stroke in patients with non-valvular atrial fibrillation.
Yasaka M; Minematsu K; Yamaguchi T
Intern Med; 2001 Dec; 40(12):1183-8. PubMed ID: 11813841
[TBL] [Abstract][Full Text] [Related]
50. Spontaneous mediastinal haematoma: a rare complication of warfarin therapy.
Jette LA; Niven AS; Nieves-Robbins N
BMJ Case Rep; 2011 Jan; 2011():. PubMed ID: 22715229
[TBL] [Abstract][Full Text] [Related]
51. Management and outcomes of cardiac tamponade during atrial fibrillation ablation in the presence of therapeutic anticoagulation with warfarin.
Latchamsetty R; Gautam S; Bhakta D; Chugh A; John RM; Epstein LM; Miller JM; Michaud GF; Oral H; Morady F; Jongnarangsin K
Heart Rhythm; 2011 Jun; 8(6):805-8. PubMed ID: 21236362
[TBL] [Abstract][Full Text] [Related]
52. Elevated International Normalized Ratio associated with concurrent use of sorafenib and warfarin.
Moretti LV; Montalvo RO
Am J Health Syst Pharm; 2009 Dec; 66(23):2123-5. PubMed ID: 19923313
[TBL] [Abstract][Full Text] [Related]
53. How can we improve our use of oral anticoagulants?
Alpert JS
Am J Med; 2006 Feb; 119(2):101-2. PubMed ID: 16443407
[No Abstract] [Full Text] [Related]
54. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
[TBL] [Abstract][Full Text] [Related]
55. Spontaneous bladder rupture secondary to warfarin overdose: a case report.
Sahin T; Oner U; Baser O; Kurtuncu I
BMC Emerg Med; 2019 Dec; 19(1):80. PubMed ID: 31849327
[TBL] [Abstract][Full Text] [Related]
56. Updated guidelines on outpatient anticoagulation.
Wigle P; Hein B; Bloomfield HE; Tubb M; Doherty M
Am Fam Physician; 2013 Apr; 87(8):556-66. PubMed ID: 23668445
[TBL] [Abstract][Full Text] [Related]
57. Warfarin therapy for an octogenarian who has atrial fibrillation.
Gage BF; Fihn SD; White RH
Ann Intern Med; 2001 Mar; 134(6):465-74. PubMed ID: 11255522
[TBL] [Abstract][Full Text] [Related]
58. Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.
Lind M; Fahlén M; Kosiborod M; Eliasson B; Odén A
Thromb Res; 2012 Jan; 129(1):32-5. PubMed ID: 21851969
[TBL] [Abstract][Full Text] [Related]
59. Life-threatening retroperitoneal bleeding due to warfarin-drug interactions.
Chan TY
Pharmacoepidemiol Drug Saf; 2009 May; 18(5):420-2. PubMed ID: 19283775
[TBL] [Abstract][Full Text] [Related]
60. Warfarin induced sublingual hematoma: a Ludwig angina mimic.
Pathak R; Supplee S; Aryal MR; Karmacharya P
Am J Otolaryngol; 2015; 36(1):84-6. PubMed ID: 25301667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
